GlaxoSmithKline (GSK) and Dentsply have entered into an agreement to create a portfolio of co-branded oral care products to be used in the dental office by patients suffering from tooth sensitivity.
In December 2009, GSK acquired NovaMin, a patent-protected calcium phosphate technology that has been clinically proven to relieve tooth sensitivity, according to the company.
The new agreement will allow Dentsply to co-brand its Nupro products, which contain the NovaMin technology, with GSK's Sensodyne brand. This co-branding will provide a continuum of care for tooth sensitivity treatment from the dental office to everyday use at home, the companies noted.
While the agreement allows Dentsply to develop a portfolio of professional tooth sensitivity products, in the short term, Dentsply will release two co-branded dental products containing the NovaMin technology:
- Nupro Sensodyne Professional prophy paste -- applied by dental professionals to provide immediate in office relief from tooth sensitivity
- Sensodyne Nupro Professional toothpaste -- a toothpaste to be dispensed by dental professionals, containing NovaMin and high fluoride for enamel remineralization
The agreement involves no exchange of cash or equity from either party.
Copyright © 2011 DrBicuspid.com
.hpp4JFpXkV.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.hpp4JFpXkV.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
